Article
NF-κB1 -94del/del ATTG polymorphic variant maintains CLL at an early, mildest stage.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 May 2021
Urbanowicz Iwona, Wołowiec Dariusz, Wysoczańska Barbara, Łacina Piotr, Jonkisz Anna, Nahaczewska Wiesława, Tukiendorf Andrzej, Bil-Lula Iwona, Bogunia-Kubik Katarzyna, Pawlak Edyta
Abstract excerpt
BACKGROUND: NF-κB is an essential player in cancer biology, especially in tumor development, due to its constitutive activation, and because a four-base deletion (ATTG) in the NF-κB1 promoter region at site -94, alters mRNA stability and regulates translation efficiency. This polymorphism is a good candidate risk marker and modulator of clinical course in chronic lymphocytic leukemia (CLL). As the effect of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
